RenovoRx RNXT
NASDAQ RNXT
$1.56 -0.01 (-0.64%)
At close: Sep 30, 2026 · 4:00 PM EDT

RenovoRx (RNXT) Receivables (2024 - 2026)

Updated

RenovoRx (RNXT) reported Receivables of $480,000 for Q2 2026, up 32.2% from $363,000 a year earlier and up 71.4% from the prior quarter.

Analysis

RenovoRx (RNXT) Receivables (2024 - 2026) Analysis & Trends

At the end of FY2025, RenovoRx posted Receivables of $139,000, up 223.3% from FY2024.

  • By year, Receivables came in at $43,000 in FY2024.
  • Year over year, Receivables has now increased in each of the last three quarters.
  • Per Business Quant data, the three quarters before Q2 2026 came in at $280,000 (Q1 2026), $139,000 (Q4 2025) and $169,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Thermo Fisher Scientific 251.30 Bn 230.45 Bn 4.88 Bn 11.14 Bn
2 Abbott Laboratories 174.70 Bn 145.78 Bn 7.27 Bn 8.60 Bn
3 Danaher 158.94 Bn 142.76 Bn 3.61 Bn 3.97 Bn
4 Intuitive Surgical 145.87 Bn 125.42 Bn 1.96 Bn 1.67 Bn
5 Medtronic 111.49 Bn 77.36 Bn 6.34 Bn 6.36 Bn
6 Stryker 106.96 Bn 93.08 Bn 4.50 Bn 3.74 Bn
7 Boston Scientific 63.62 Bn 58.63 Bn 3.85 Bn 3.05 Bn
8 Edwards Lifesciences 50.80 Bn 34.92 Bn 1.35 Bn 955.70 Mn
9 Becton Dickinson 49.59 Bn 46.74 Bn 2.32 Bn 2.36 Bn
10 RenovoRx 70.84 Mn 70.84 Mn 766,000.00 480,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 480,000.00
Mar 31, 2026 280,000.00
Dec 31, 2025 139,000.00
Sep 30, 2025 169,000.00
Jun 30, 2025 363,000.00
Mar 31, 2025 242,000.00
Dec 31, 2024 43,000.00
API Access

RenovoRx Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=RNXT&period=max&api_key=YOUR_API_KEY